Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies

Charles A. Staley; Wayne B. Harris; Jerome Landry; William Small; David Kooby; Theresa W. Gillespie; Mary Meyers; Kapil N. Bhalla

doi:10.1016/j.soc.2004.06.011

Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies

Charles A. Staley, Wayne B. Harris, Jerome Landry, William Small, David Kooby, Theresa W. Gillespie, Mary Meyers, Kapil N. Bhalla

Dr. Mary and Ron Neal Cancer Center

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.

Original language	English (US)
Pages (from-to)	697-709
Number of pages	13
Journal	Surgical Oncology Clinics of North America
Volume	13
Issue number	4
DOIs	https://doi.org/10.1016/j.soc.2004.06.011
State	Published - Oct 2004

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.soc.2004.06.011

Cite this

Staley, C. A., Harris, W. B., Landry, J., Small, W., Kooby, D., Gillespie, T. W., Meyers, M., & Bhalla, K. N. (2004). Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies. Surgical Oncology Clinics of North America, 13(4), 697-709. https://doi.org/10.1016/j.soc.2004.06.011

Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies. / Staley, Charles A.; Harris, Wayne B.; Landry, Jerome et al.
In: Surgical Oncology Clinics of North America, Vol. 13, No. 4, 10.2004, p. 697-709.

Research output: Contribution to journal › Review article › peer-review

Staley, CA, Harris, WB, Landry, J, Small, W, Kooby, D, Gillespie, TW, Meyers, M & Bhalla, KN 2004, 'Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies', Surgical Oncology Clinics of North America, vol. 13, no. 4, pp. 697-709. https://doi.org/10.1016/j.soc.2004.06.011

@article{2683e8ed78124892882ef68e6693b24d,

title = "Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies",

abstract = "The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.",

author = "Staley, \{Charles A.\} and Harris, \{Wayne B.\} and Jerome Landry and William Small and David Kooby and Gillespie, \{Theresa W.\} and Mary Meyers and Bhalla, \{Kapil N.\}",

year = "2004",

month = oct,

doi = "10.1016/j.soc.2004.06.011",

language = "English (US)",

volume = "13",

pages = "697--709",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - Neoadjuvant induction chemotherapy followed by chemoradiation

T2 - A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies

AU - Staley, Charles A.

AU - Harris, Wayne B.

AU - Landry, Jerome

AU - Small, William

AU - Kooby, David

AU - Gillespie, Theresa W.

AU - Meyers, Mary

AU - Bhalla, Kapil N.

PY - 2004/10

Y1 - 2004/10

N2 - The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.

AB - The authors developed a strategy that includes a novel approach of induction full-dose chemotherapy followed by traditional chemoradiation as a neoadjuvant therapy for pancreatic cancer. Here they report the results of a phase I/II trial of gemcitabine, cisplatin, and 5-FU for patients with advanced gastrointestinal malignancies.

UR - https://www.scopus.com/pages/publications/4444338194

UR - https://www.scopus.com/inward/citedby.url?scp=4444338194&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2004.06.011

DO - 10.1016/j.soc.2004.06.011

M3 - Review article

C2 - 15350943

AN - SCOPUS:4444338194

SN - 1055-3207

VL - 13

SP - 697

EP - 709

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 4

ER -

Neoadjuvant induction chemotherapy followed by chemoradiation: A phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this